Global Insomnia Therapeutics Market Size study & Forecast, by Product (Drugs, Device) by Sales Channel (Prescription, Over-the-Counter (OTC))and Regional Analysis, 2022-2029
Global Insomnia Therapeutics Market is valued at approximately USD 2.8 billion in 2021and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2022-2029.Insomnia Therapeutics is the treatment effective in preventing Insomnia. It is a sleep disorder that creates difficulty for the individual to fall or stay asleep. It is a very common disease prevailing these days and affecting a number of populations. There are several reasons for this disorder such as stress, poor sleep schedules, bad sleeping habits, anxiety and so on. It also affects mental health, work performance and quality of individual life. Additionally, increasing incidences of stress among individuals and the positive impact of COVID-19 on the insomnia market are driving the market for Insomnia Therapeutics.
The increasing stress levels among the global population due to several reasons lead to insomnia further driving the market for Insomnia Therapeutics. For instance, in 2022 50% of respondents were feeling more stressed than in the previousyear. In 2019 the percentage was just 38%. The stress can be due to workload, family issues, personal health care, and individual mental health. All age groups were affected due to this sleep disorder due to different reasons. The pandemic COVID-19 laid a positive impact on the Insomnia market. People suffered from stress due to job losses and unexpected situations. Such a deadly life event surged the demand for insomnia therapeutics in the market. Around 67% of respondents experienced higher levelsof stress during the pandemic globally in 2020. Moreover, the constant rise in hectic schedules of individuals, and continuous advancements and formulations in better insomnia treatment methods boosted the demand. However, the high cost of Insomnia Therapeutics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Insomnia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for Insomnia therapeutics with a share of 54%. The growing geriatricc population and high prevalence of insomnia in this population is driving the market for Insomnia Therapeutics. The growing investments of key market players in R&D and innovations through frequent product launches play a major role in market demand. Asia-Pacific is expected to be the fastest-growing region due to increased stress and work schedules affecting sleep among the population is leading to insomnia disorders. The rising awareness to cure for sleep disorders is boosting the market demand.
Major market player included in this report are:
Takeda Pharmaceutical Company Ltd.;
Idorsia Pharmaceuticals Ltd
Eisai Co., Ltd.
Pfizer Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Electromedical Products International, Inc.
Paratek Pharmaceuticals, Inc.
Sumitomo Pharma Co., Ltd.
Recent Developments in the Market:
In May 2022, QUVIVIQ a medication to treat adult patients with insomnia launched by Idorsia Ltd received approval from European Commission. The symptoms should be for at least 3 months and impact daytime working.
In June 2021, DAYVIGO was launched by Eisai Co., Ltd., a global leader in life science products. This launch was to treat insomnia in adults. It was also approved by U.S. Food and Drug Administration (FDA).
Global Insomnia Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Sales Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByProduct:
Drugs
Device
By Sales Channel:
Prescription
Over-the-Counter (OTC)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
The increasing stress levels among the global population due to several reasons lead to insomnia further driving the market for Insomnia Therapeutics. For instance, in 2022 50% of respondents were feeling more stressed than in the previousyear. In 2019 the percentage was just 38%. The stress can be due to workload, family issues, personal health care, and individual mental health. All age groups were affected due to this sleep disorder due to different reasons. The pandemic COVID-19 laid a positive impact on the Insomnia market. People suffered from stress due to job losses and unexpected situations. Such a deadly life event surged the demand for insomnia therapeutics in the market. Around 67% of respondents experienced higher levelsof stress during the pandemic globally in 2020. Moreover, the constant rise in hectic schedules of individuals, and continuous advancements and formulations in better insomnia treatment methods boosted the demand. However, the high cost of Insomnia Therapeutics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Insomnia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for Insomnia therapeutics with a share of 54%. The growing geriatricc population and high prevalence of insomnia in this population is driving the market for Insomnia Therapeutics. The growing investments of key market players in R&D and innovations through frequent product launches play a major role in market demand. Asia-Pacific is expected to be the fastest-growing region due to increased stress and work schedules affecting sleep among the population is leading to insomnia disorders. The rising awareness to cure for sleep disorders is boosting the market demand.
Major market player included in this report are:
Takeda Pharmaceutical Company Ltd.;
Idorsia Pharmaceuticals Ltd
Eisai Co., Ltd.
Pfizer Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Electromedical Products International, Inc.
Paratek Pharmaceuticals, Inc.
Sumitomo Pharma Co., Ltd.
Recent Developments in the Market:
In May 2022, QUVIVIQ a medication to treat adult patients with insomnia launched by Idorsia Ltd received approval from European Commission. The symptoms should be for at least 3 months and impact daytime working.
In June 2021, DAYVIGO was launched by Eisai Co., Ltd., a global leader in life science products. This launch was to treat insomnia in adults. It was also approved by U.S. Food and Drug Administration (FDA).
Global Insomnia Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Sales Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByProduct:
Drugs
Device
By Sales Channel:
Prescription
Over-the-Counter (OTC)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Insomnia Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Insomnia Therapeutics Market, by Product,2019-2029 (USD Billion)
1.2.3. Insomnia Therapeutics Market, by Sales Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INSOMNIA THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INSOMNIA THERAPEUTICS MARKET DYNAMICS
3.1. Insomnia Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Stress.
3.1.1.2. Positive Impact of COVID-19.
3.1.2. Market Challenges
3.1.2.1. High Cost of Insomnia Therapeutics
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation.
3.1.3.2. Rising hectic work schedule.
CHAPTER 4. GLOBAL INSOMNIA THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL INSOMNIA THERAPEUTICS MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Insomnia Therapeutics Market by Product, Performance - Potential Analysis
6.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Insomnia Therapeutics Market, Sub Segment Analysis
6.4.1. Drugs
6.4.2. Device
CHAPTER 7. GLOBAL INSOMNIA THERAPEUTICS MARKET, BY SALES CHANNEL
7.1. Market Snapshot
7.2. Global Insomnia Therapeutics Market by Sales Channel, Performance - Potential Analysis
7.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Sales Channel 2019-2029 (USD Billion)
7.4. Insomnia Therapeutics Market, Sub Segment Analysis
7.4.1. Prescription
7.4.2. Over-the-Counter (OTC)
CHAPTER 8. GLOBAL INSOMNIA THERAPEUTICS MARKET, REGIONAL ANALYSIS
8.1. Insomnia Therapeutics Market, Regional Market Snapshot
8.2. North America Insomnia Therapeutics Market
8.2.1. U.S.Insomnia Therapeutics Market
8.2.1.1. Productbreakdown estimates & forecasts, 2019-2029
8.2.1.2. Sales Channel breakdown estimates & forecasts, 2019-2029
8.2.2. CanadaInsomnia Therapeutics Market
8.3. Europe Insomnia Therapeutics Market Snapshot
8.3.1. U.K. Insomnia Therapeutics Market
8.3.2. Germany Insomnia Therapeutics Market
8.3.3. France Insomnia Therapeutics Market
8.3.4. Spain Insomnia Therapeutics Market
8.3.5. Italy Insomnia Therapeutics Market
8.3.6. Rest of EuropeInsomnia Therapeutics Market
8.4. Asia-PacificInsomnia Therapeutics Market Snapshot
8.4.1. China Insomnia Therapeutics Market
8.4.2. India Insomnia Therapeutics Market
8.4.3. JapanInsomnia Therapeutics Market
8.4.4. Australia Insomnia Therapeutics Market
8.4.5. South Korea Insomnia Therapeutics Market
8.4.6. Rest of Asia PacificInsomnia Therapeutics Market
8.5. Latin America Insomnia Therapeutics Market Snapshot
8.5.1. Brazil Insomnia Therapeutics Market
8.5.2. MexicoInsomnia Therapeutics Market
8.6. Rest of The World Insomnia Therapeutics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Takeda Pharmaceutical Company Ltd.;
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. ProductSummary
9.2.1.5. Recent Developments
9.2.2. Idorsia Pharmaceuticals Ltd
9.2.3. Eisai Co., Ltd.
9.2.4. Pfizer Inc.
9.2.5. Merck & Co., Inc.
9.2.6. Teva Pharmaceutical Industries Ltd.
9.2.7. Sanofi S.A.
9.2.8. Electromedical Products International, Inc.
9.2.9. Paratek Pharmaceuticals, Inc.
9.2.10. Sumitomo Pharma Co., Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Insomnia Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Insomnia Therapeutics Market, by Product,2019-2029 (USD Billion)
1.2.3. Insomnia Therapeutics Market, by Sales Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INSOMNIA THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INSOMNIA THERAPEUTICS MARKET DYNAMICS
3.1. Insomnia Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Stress.
3.1.1.2. Positive Impact of COVID-19.
3.1.2. Market Challenges
3.1.2.1. High Cost of Insomnia Therapeutics
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation.
3.1.3.2. Rising hectic work schedule.
CHAPTER 4. GLOBAL INSOMNIA THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL INSOMNIA THERAPEUTICS MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Insomnia Therapeutics Market by Product, Performance - Potential Analysis
6.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Insomnia Therapeutics Market, Sub Segment Analysis
6.4.1. Drugs
6.4.2. Device
CHAPTER 7. GLOBAL INSOMNIA THERAPEUTICS MARKET, BY SALES CHANNEL
7.1. Market Snapshot
7.2. Global Insomnia Therapeutics Market by Sales Channel, Performance - Potential Analysis
7.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Sales Channel 2019-2029 (USD Billion)
7.4. Insomnia Therapeutics Market, Sub Segment Analysis
7.4.1. Prescription
7.4.2. Over-the-Counter (OTC)
CHAPTER 8. GLOBAL INSOMNIA THERAPEUTICS MARKET, REGIONAL ANALYSIS
8.1. Insomnia Therapeutics Market, Regional Market Snapshot
8.2. North America Insomnia Therapeutics Market
8.2.1. U.S.Insomnia Therapeutics Market
8.2.1.1. Productbreakdown estimates & forecasts, 2019-2029
8.2.1.2. Sales Channel breakdown estimates & forecasts, 2019-2029
8.2.2. CanadaInsomnia Therapeutics Market
8.3. Europe Insomnia Therapeutics Market Snapshot
8.3.1. U.K. Insomnia Therapeutics Market
8.3.2. Germany Insomnia Therapeutics Market
8.3.3. France Insomnia Therapeutics Market
8.3.4. Spain Insomnia Therapeutics Market
8.3.5. Italy Insomnia Therapeutics Market
8.3.6. Rest of EuropeInsomnia Therapeutics Market
8.4. Asia-PacificInsomnia Therapeutics Market Snapshot
8.4.1. China Insomnia Therapeutics Market
8.4.2. India Insomnia Therapeutics Market
8.4.3. JapanInsomnia Therapeutics Market
8.4.4. Australia Insomnia Therapeutics Market
8.4.5. South Korea Insomnia Therapeutics Market
8.4.6. Rest of Asia PacificInsomnia Therapeutics Market
8.5. Latin America Insomnia Therapeutics Market Snapshot
8.5.1. Brazil Insomnia Therapeutics Market
8.5.2. MexicoInsomnia Therapeutics Market
8.6. Rest of The World Insomnia Therapeutics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Takeda Pharmaceutical Company Ltd.;
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. ProductSummary
9.2.1.5. Recent Developments
9.2.2. Idorsia Pharmaceuticals Ltd
9.2.3. Eisai Co., Ltd.
9.2.4. Pfizer Inc.
9.2.5. Merck & Co., Inc.
9.2.6. Teva Pharmaceutical Industries Ltd.
9.2.7. Sanofi S.A.
9.2.8. Electromedical Products International, Inc.
9.2.9. Paratek Pharmaceuticals, Inc.
9.2.10. Sumitomo Pharma Co., Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Insomnia Therapeutics Market, report scope
TABLE 2. Global Insomnia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Insomnia Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Insomnia Therapeutics Market estimates & forecasts by Sales Channel 2019-2029 (USD Billion)
TABLE 5. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPACInsomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Insomnia Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Insomnia Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Insomnia Therapeutics Market, report scope
TABLE 2. Global Insomnia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Insomnia Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Insomnia Therapeutics Market estimates & forecasts by Sales Channel 2019-2029 (USD Billion)
TABLE 5. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPACInsomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Insomnia Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Insomnia Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Insomnia Therapeutics Market, research methodology
FIG 2. Global Insomnia Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Insomnia Therapeutics Market, key trends 2021
FIG 5. Global Insomnia Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Insomnia Therapeutics Market, porters 5 force model
FIG 7. Global Insomnia Therapeutics Market, pest analysis
FIG 8. Global Insomnia Therapeutics Market, value chain analysis
FIG 9. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Insomnia Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 16. Europe Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 17. Asia pacific Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 18. Latin America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 19. Global Insomnia Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Insomnia Therapeutics Market, research methodology
FIG 2. Global Insomnia Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Insomnia Therapeutics Market, key trends 2021
FIG 5. Global Insomnia Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Insomnia Therapeutics Market, porters 5 force model
FIG 7. Global Insomnia Therapeutics Market, pest analysis
FIG 8. Global Insomnia Therapeutics Market, value chain analysis
FIG 9. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Insomnia Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 16. Europe Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 17. Asia pacific Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 18. Latin America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
FIG 19. Global Insomnia Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
